.
Ataxia with oculomotor apraxia type 2 is a rare autosomal recessive cerebellar ataxia caused by senataxin gene mutations, with minimal published data on anaesthetic management. We report the peri-operative care of a 46-year-old woman with genetically confirmed ataxia with oculomotor apraxia type 2 undergoing laparoscopic cholecystectomy under general anaesthesia. Key challenges included uncertain sensitivity to neuromuscular blocking agents and the potential for respiratory weakness and bulbar dysfunction. Non-technical challenges arose from incomplete recognition and communication of the condition pre-operatively. Anaesthetic strategy prioritised titratable, reversible agents and careful intra-operative monitoring. Rocuronium was administered in reduced dose with quantitative neuromuscular monitoring and fully reversed with sugammadex prior to tracheal extubation. Propofol, sevoflurane and remifentanil target-controlled infusion were used to ensure haemodynamic stability and minimise cumulative opioid exposure. The patient recovered uneventfully with no residual weakness or respiratory impairment. To our knowledge, this is the first published description of general anaesthesia for laparoscopic surgery in a patient with ataxia with oculomotor apraxia type 2. It demonstrates that anaesthesia can be safely delivered to patients with this condition with careful pre-operative planning.
Perinatal asphyxia is a critical condition frequently associated with hemodynamic instability, often necessitating vasoactive support. Despite the established benefits of therapeutic hypothermia, significant mortality and long-term morbidity persist, particularly in severe cases. The objective of this narrative review is to critically evaluate the available evidence on vasoactive therapies in asphyxiated neonates, compare the hemodynamic effects of commonly used agents, and propose a physiology-based, phenotype-driven approach to cardiovascular management during therapeutic hypothermia. Available evidence remains limited and heterogeneous, with few high-quality studies specifically addressing this population. While commonly used vasoactive agents exert distinct physiologic effects, no single agent has demonstrated clear superiority in improving clinical outcomes. Current evidence supports an individualized, physiology-based approach to vasoactive therapy guided by the underlying hemodynamic phenotype and informed by multimodal monitoring. Further prospective studies are needed to define optimal therapeutic strategies and improve outcomes in this high-risk population.
Severe sepsis presents a critical healthcare challenge where rapid pathogen identification is vital for timely intervention. Current diagnostic methods, however, remain inadequate, often delaying targeted treatment. Using readily available printed circuit board (PCB) electrodes, we address this need by developing a low-cost electrochemical DNA biosensor for rapid detection of Streptococcus pneumoniae using the lytA gene as a biomarker. Through systematic evaluation of commercial and custom PCB designs (P1-P4), gold-plated PCB P4 was found as the optimal platform, demonstrating sensitive detection of lytA sequences (20 bp at 4.50 pM limit of detection in buffer) and clinically relevant 235 bp polymerase chain reaction (PCR) amplicons in 100% human serum (1.0-100 pM) within 15 min at room temperature using electrochemical impedance spectroscopy. The performance of the biosensor originates from the optimized electrode geometry, surface properties, and robust self-assembled monolayer functionalization, enabling specific recognition of bacterial DNA without sample pretreatment. This work establishes PCB-based biosensors as a promising solution for point-of-care sepsis diagnostics, offering significant advantages in speed, cost, and operational simplicity compared to conventional methods.
Objectives Frostbite is a common reason for emergency department (ED) presentations in Canada. Iloprost, a prostacyclin analogue, has been investigated to reduce the risk of amputation with its use expanding. Two Canadian cities implemented iloprost over different times leading to a practice variation that allowed for treatment comparison. Our objective is to evaluate the effectiveness of iloprost compared with non-iloprost treatment. Secondary objectives include assessing the impact of iloprost dosage and homelessness.Methods A retrospective cohort study was conducted on adult severe frostbite cases presenting to EDs in Calgary and Edmonton between November 2021 and April 2024. Data were abstracted from clinical databases and analysed for demographic and injury characteristics, treatment and amputation outcomes.Results Of 1812 total ED encounters for frostbite, 257 patients with grades 2–4 extremity frostbite were included for analysis. Logistic regression found that overall patients receiving iloprost were associated with reduced likelihood of any amputation (OR=0.49, 95% CI 0.25 to 0.96) and fewer digit amputations (p<0.001). In particular, iloprost use was associated with reduced amputation rates in grade 3 injuries compared with non-iloprost care (30% vs 52%, p=0.042). Although over 80% of patients with grade 4 frostbite required amputations regardless of iloprost treatment, its use was associated with improved digit salvage, with 10% fewer digit segments requiring amputation in treated patients in both hands (p=0.049) and feet (p=0.003). When assessing 65 patients who received iloprost for limb frostbite, higher iloprost doses were associated with a lower likelihood of amputation (OR=0.35; 95% CI 0.13 to 0.91; p=0.03). In the patient subgroup who underwent at least one amputation, total iloprost dosage was inversely related to outcome (p=0.033, βST=−0.26). Adverse events were reported in 61% of iloprost-treated patients, with headache being the most common. Homelessness was found to be a significant predictor of delays in arrival to the ED after injury (p<0.001); OR=2.90 (95% CI 1.73 to 4.91).Conclusions Iloprost infusion was associated with a reduction in amputation rates in grade 3 and 4 frostbite with the greatest association seen in grade 3 cases. Greater iloprost dosage was associated with improved digit salvage. Homelessness was associated with delayed ED presentation.
OBJECTIVE:To identify patient-centered approaches to pressure injury (PI) prevention and management for adults in acute care settings, including the strategies used and their effectiveness. DATA SOURCES:A comprehensive search strategy was developed using the JBI Participants, Concept, and Context framework. The authors searched EMBASE, CINAHL, MEDLINE, Scopus, Cochrane Library, ProQuest, the James Lind Alliance, Healthcare Excellence Canada, and PI-specific organizations for English-language publications from the past 10 years. STUDY SELECTION:The search identified 3055 articles, and 1422 duplicates were removed. Studies were excluded if they did not focus on patient-centered PI prevention and management, did not occur in acute care settings, or did not include data that could be extracted. Following abstract and full-text screening, 21 studies were included in this review. DATA EXTRACTION:Two independent reviewers extracted data on study design, interventions, and outcomes, and quality (using the Mixed Methods Appraisal Tool). DATA SYNTHESIS:The included studies reported 4 main PI prevention strategies: care bundles, educational interventions, technological interventions, or tools to assess or reduce PI risk. Quantitative findings consistently showed reduced PI incidence with patient-centered interventions. Qualitative studies emphasized the importance of knowledge, communication, and collaboration in enhancing patient involvement. Barriers to engagement included pain, cognitive impairment, and health care provider time constraints. The methodological quality of the included studies varied, with limitations due to a lack of blinding and incomplete outcome data. CONCLUSIONS:Patient-centered approaches can effectively reduce PI incidence in acute care. Future interventions should incorporate consistent education, tailored care plans, and effective communication to enhance patient engagement and improve PI prevention and management.